| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2011: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2010: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2009: ¥2,470,000 (Direct Cost: ¥1,900,000、Indirect Cost: ¥570,000)
|
|---|
| Research Abstract |
Harm reduction is one of the most important measures for drug problems in EU today. It can be seen as a medicalized and welfare-based measure for drug users. The process whereby harm reduction became major in EU is related to the process whereby European countries developed their cooperative social policies including welfare for labors, with which economical cooperation among European countries was promoted. The process also has been supported by the principle of subsidiarity in EU, which enabled the cooperations with municipals among European countries. Many practical situations of harm reduction are supported by the discourse of workfare, which is derived from one of the leading thoughts and discourses of welfare policies in EU.
|
